Convatec Group Plc Announces Director/PDMR Shareholding
The healthcare company has disclosed details of share option grants to its Interim CEO and Interim CFO under the company's 2017 Save As You Earn scheme.
The healthcare company has disclosed details of share option grants to its Interim CEO and Interim CFO under the company's 2017 Save As You Earn scheme.
The medical products company has announced details of director and PDMR shareholding changes under its employee share option scheme.
The healthcare company has announced that an interim executive has exercised share options under an employee scheme.
The healthcare company's interim CEO and CFO have purchased additional shares in the business.
The healthcare company has received a notification regarding a change in major shareholding.
The healthcare company is launching a share buyback programme to return up to $300 million to shareholders.
The healthcare company has received a notification regarding a change in major shareholding.
The healthcare company has made a regulatory filing, but no further details are provided.
The CEO of the medical products company has sold a portion of his shareholding, citing personal reasons unrelated to the business.
The healthcare company announces its CEO will be taking a medical leave of absence, with the CFO becoming Interim CEO during this period.